CA
COGT icon

CHI Advisors’s Cogent Biosciences COGT Stock Holding History

CHI Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-235,201
Closed -$433K – 23
2020
Q2 		$433K Hold
235,201
– – 0.17% 19
2020
Q1 		$389K Hold
235,201
– – 0.92% 12
2019
Q4 		$678K Buy
235,201
+37,500
+19% +$153K 0.51% 11
2019
Q3 		$1.14M Buy
+197,701
New +$1.61M 1.11% 9

Other funds holding COGT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors's COGT Position: Q3 2020 in Review

CHI Advisors sold out of Cogent Biosciences (COGT) in Q3 2020, closing a stake of 235,201 shares — an estimated $433K sold.

CHI Advisors first reported a position in COGT in Q3 2019 and held it in 4 quarters. The position peaked at $1.14M in Q3 2019. 35 funds tracked by Wall St. Rank hold COGT as of Q3 2020.

  • CHI Advisors reported no remaining Cogent Biosciences position as of Q3 2020 after selling out during the quarter.
  • CHI Advisors sold 235,201 Cogent Biosciences shares in Q3 2020, an estimated $433K.
  • CHI Advisors first reported a position in Cogent Biosciences in Q3 2019 and held it in 4 quarters.
  • CHI Advisors's Cogent Biosciences position peaked at $1.14M in Q3 2019.
  • 35 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2020.

Based on CHI Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.